Literature DB >> 22473770

Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics.

Sung-Min Kim1, Min Jin Go, Jung-Joon Sung, Kyung Seok Park, Kwang-Woo Lee.   

Abstract

OBJECTIVES: To evaluate the diagnostic utility and clinical characteristics of painful tonic spasm (PTS) in neuromyelitis optica (NMO).
DESIGN: Retrospective study.
SETTING: Two referral hospitals. PATIENTS: Forty patients who had NMO spectrum disorder with anti-aquaporin 4 autoantibody or met the revised diagnostic criteria for definite NMO; 35 patients with multiple sclerosis; and 41 patients with idiopathic acute transverse myelitis without anti-aquaporin 4 antibody. MAIN OUTCOME MEASURES: The incidence and clinical characteristics of PTS in the different groups, diagnostic value of PTS in identifying patients with NMO, and predictors of PTS in NMO.
RESULTS: The incidence of PTS was significantly higher in the patients with NMO (10 patients [25.0%]) than in those with multiple sclerosis (1 patient [2.9%]) or idiopathic acute transverse myelitis without anti-aquaporin 4 antibody (1 patient [2.4%]). Most PTS episodes (in 8 of 10 patients [80.0%]) in the NMO group occurred after a mean interval of 48.13 days from the onset of the first myelitis episode and were not accompanied by another demyelinating episode with its onset. Painful tonic spasm associated with myelitis had a specificity of 98.7% for identifying the NMO group. Myelitis at disease onset was a predictor of PTS in the NMO group (odds ratio = 6.545, presence vs absence).
CONCLUSIONS: Painful tonic spasm is a common symptom in NMO. When associated with myelitis, it is relatively specific to patients with NMO and is most commonly observed during recovery from the first myelitis episode. Patients with NMO presenting with myelitis at disease onset appear to be at higher risk for developing PTS compared with other patients with NMO.

Entities:  

Mesh:

Year:  2012        PMID: 22473770     DOI: 10.1001/archneurol.2012.112

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  24 in total

Review 1.  Neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

2.  Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker; Karl N Krecke; Vanda A Lennon; Claudia F Lucchinetti; Andrew McKeon; Dean M Wingerchuk; Elizabeth A Shuster; Yujuan Jiao; Erika S Horta; Sean J Pittock
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

Review 3.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Ann N Y Acad Sci       Date:  2015-06-10       Impact factor: 5.691

4.  Sleep Quality in Neuromyelitis Optica Spectrum Disorder: A Systematic Review.

Authors:  Arshia Eshtiaghi; David Eapen-John; Kirill Zaslavsky; Reza Vosoughi; Brian J Murray; Edward Margolin
Journal:  Int J MS Care       Date:  2021-08-18

Review 5.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.

Authors:  Elia Sechi; Laura Cacciaguerra; John J Chen; Sara Mariotto; Giulia Fadda; Alessandro Dinoto; A Sebastian Lopez-Chiriboga; Sean J Pittock; Eoin P Flanagan
Journal:  Front Neurol       Date:  2022-06-17       Impact factor: 4.086

Review 6.  From Collar to Coccyx: Truncal Movement Disorders: A Clinical Review.

Authors:  Fabiana Colucci; Vanessa Carvalho; Cristina Gonzalez-Robles; Kailash P Bhatia; Eoin Mulroy
Journal:  Mov Disord Clin Pract       Date:  2021-08-26

Review 7.  What's new in neuromyelitis optica? A short review for the clinical neurologist.

Authors:  Daniel Whittam; Martin Wilson; Shahd Hamid; Geoff Keir; Maneesh Bhojak; Anu Jacob
Journal:  J Neurol       Date:  2017-03-13       Impact factor: 4.849

Review 8.  Pain in neuromyelitis optica--prevalence, pathogenesis and therapy.

Authors:  Monika Bradl; Yoko Kanamori; Ichiro Nakashima; Tatsuro Misu; Kazuo Fujihara; Hans Lassmann; Jürgen Sandkühler
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

9.  Spinal Movement Disorders in Neuromyelitis Optica: An Under-recognized Phenomenon.

Authors:  Hesham Abboud; Hubert H Fernandez; Maureen A Mealy; Michael Levy
Journal:  Mov Disord Clin Pract       Date:  2016-02-11

10.  Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report.

Authors:  Anne Waschbisch; Bernd Kallmünzer; Stefan Schwab; Philipp Gölitz; Angela Vincent; De-Hyung Lee; Ralf A Linker
Journal:  BMC Res Notes       Date:  2014-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.